94 related articles for article (PubMed ID: 23823098)
1. [Myeloid/natural killer cell precursor acute leukemia diagnosed by cell marker analysis].
Miura R; Yoshimi M; Kikuchi Y; Takahashi T
Rinsho Ketsueki; 2013 Jun; 54(6):579-83. PubMed ID: 23823098
[TBL] [Abstract][Full Text] [Related]
2. Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis.
Ogura K; Kimura F; Kobayashi S; Torikai H; Ikeda T; Sato K; Motoyoshi K
Leuk Res; 2006 Jun; 30(6):761-3. PubMed ID: 16140376
[TBL] [Abstract][Full Text] [Related]
3. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukemia.
Inaba T; Shimazaki C; Sumikuma T; Ochiai N; Okano A; Hatsuse M; Ashihara E; Kobayashi Y; Rin K; Murakami S; Haruyama H; Fujita N; Nakagawa M
Leuk Res; 2001 Feb; 25(2):109-13. PubMed ID: 11166825
[TBL] [Abstract][Full Text] [Related]
5. Myeloid/natural killer cell precursor acute leukemia with tetraploidy.
Dinçol G; Palandüz S; Nalçaci M; Uçur A; Büyükaydin B
Cancer Genet Cytogenet; 2005 Dec; 163(2):156-9. PubMed ID: 16337859
[TBL] [Abstract][Full Text] [Related]
6. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
7. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report.
Hashimoto S; Toba K; Aoki S; Tsuchiyama J; Tsukada N; Takahashi H; Takahashi M; Aizawa Y
Leuk Res; 2002 Feb; 26(2):215-9. PubMed ID: 11755472
[TBL] [Abstract][Full Text] [Related]
8. [Myeloid/natural killer cell precursor and myeloid/natural killer cell acute leukemia].
Ni M; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):525-9. PubMed ID: 24763036
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
10. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
11. Myeloid/NK cell acute leukemia.
Chen B; Xu X; Ji M; Lin G
Int J Hematol; 2009 Apr; 89(3):365-367. PubMed ID: 19326059
[TBL] [Abstract][Full Text] [Related]
12. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
Liu YR; Zhu HH; Ruan GR; Qin YZ; Shi HX; Lai YY; Chang Y; Wang YZ; Lu D; Hao L; Li JL; Li LD; Jiang B; Huang XJ
Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747
[TBL] [Abstract][Full Text] [Related]
13. Childhood myeloid/natural killer precursor acute leukemia with novel chromosomal aberrations der(5)t(4;5)(q31;q31.3) and t(14;17)(q32;q23).
Abdelhaleem M; Shago M; Sayeh E; Abla O
Cancer Genet Cytogenet; 2007 Oct; 178(2):141-3. PubMed ID: 17954270
[TBL] [Abstract][Full Text] [Related]
14. [CD7(+) acute myeloid leukemia (M0) associated with a mediastinal bulky mass lesion].
Yoshida K; Kusumoto S; Sugahara Y; Yagasaki F; Sakata T; Kawai N; Matsuda A; Suzuki T; Hirashima K; Kayano H; Bessho M
Rinsho Ketsueki; 2001 Aug; 42(8):644-9. PubMed ID: 11579505
[TBL] [Abstract][Full Text] [Related]
15. CD56-positive acute lymphoblastic leukemia.
Matano S; Terahata S; Nakamura S; Kobayashi K; Sugimoto T
Acta Haematol; 2005; 114(3):160-3. PubMed ID: 16227680
[TBL] [Abstract][Full Text] [Related]
16. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
[TBL] [Abstract][Full Text] [Related]
17. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
Lotzová E; Savary CA
Nat Immun; 1993; 12(4-5):209-17. PubMed ID: 8257827
[TBL] [Abstract][Full Text] [Related]
18. Secondary myeloid/natural killer cell precursor acute leukemia following essential thrombocythemia.
Nagai M; Bandoh S; Tasaka T; Fujita M; Yamauchi A; Kuwabara H; Funamoto Y; Yamaoka G; Takahara J
Hum Pathol; 1999 Jul; 30(7):868-71. PubMed ID: 10414508
[TBL] [Abstract][Full Text] [Related]
19. Myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as FAB-M3 acute myeloid leukemia.
Paietta E; Gallagher RE; Wiernik PH
Blood; 1994 Oct; 84(8):2824-5. PubMed ID: 7522645
[No Abstract] [Full Text] [Related]
20. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
Owatari S; Otsuka M; Takeshita T; Mizukami K; Suzuki S; Uozumi K; Tashiro Y; Arima N; Hanada S
Int J Hematol; 2009 Mar; 89(2):188-194. PubMed ID: 19109730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
